跳至主要内容
临床试验/EUCTR2020-001103-17-BE
EUCTR2020-001103-17-BE进行中(未招募)1 期

Gut microbiota, pharmacogenetics and Integrase Strand Transfer Inhibitors response - INSTI

Cliniques universitaires Saint-Luc0 个研究点目标入组 200 人开始时间: 2020年12月1日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • -HIV infected adult patient regularly followed at Centre de reference HIV of CUSL and currently treated by DTG (n=80) or BIC (n=30).
  • -Virally controlled immunologically functional HIV infected adult patient regularly followed at Centre de reference HIV of CUSL and shifting from another ARV class to DTG (n=20) or BIC (n=20).
  • -HIV infected adult patient retrospectively identified as having stopped DTG due to NPAE (insomnia, depression, anxiety) (n=50). Identification will be based on the interrogation of our prospective clinical database.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 150
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • -Pregnancy at the time of inclusion or expected pregnancy within 12 months, for patients treated by DTG or BIC during the study
  • -Liver failure (Child-Pugh A, B or C)

研究者

相似试验